Immunotherapy-Based Combinations for Advanced Melanoma: Best Practices, Key Developments, and a Look at the Horizon

Immunotherapy-Based Combinations for Advanced Melanoma: Best Practices, Key Developments, and a Look at the Horizon is organized by Med Learning Group.

Released Date: July 15, 2024
Expiration Date: July 15, 2025

Description:
This online enduring program will provide healthcare providers with information needed to select first-line treatment for patients with unresectable or metastatic melanoma by incorporating evidence-based guidelines and applying current clinical trial data. This program will also review best practices for the management of adverse events associated with immunotherapy for unresectable or metastatic melanoma, as well as outline combination immunotherapy strategies for patients with advanced melanoma.

Learning Objectives:
Upon the completion of this program, attendees should be able to:

• Select first-line treatment for patients with unresectable or metastatic melanoma based on evidence-based guidelines and the most recent data from clinical trials of immunotherapy
• Discuss best practices for overall management of adverse events associated with single-agent or combination immunotherapy for unresectable or metastatic melanoma
• Review ongoing clinical trials of emerging combination immunotherapy strategies for melanoma.